
On February 3, the final workshop of the European Smart4Fabry project will be held. Smart4Fabry is an initiative whose objective is to obtain a new GLA nanoformulation to address Fabry disease, achieving relevant improvements on the efficacy and tolerance of the treatments based on enzyme replacement therapies. Our technology transfer director Alba Córdoba will lead the session dealing with Production Optimization and Scale-up of the nanoformulation and our CEO Santi Sala will contribute to the final round table.
Online venue:
Further relevant information regarding the event will be provided on https://smart4fabry.eu/